Electronic Signatures and Clinical Trial Research Agreement execution in Australia CT:IQ together with Medicines Australia (MA), Medical Technology Association of Australia (MTAA) and AusBiotech have released a joint position statement confirming that eSignatures can be used to execute clinical trial research agreements (CTRAs) in Australia. Read the statement below or access Joint Position Statement [PDF: […]
News
Register for our eNews
Illingworth Research Group joins Steering Committee
We are delighted to welcome Illingworth Research Group (Australia) Pty Ltd to CT:IQ’s Steering Committee. Illingworth specialises in making clinical trial participation more accessible and convenient for patients and their carers by providing a range of patient centric services to the CRO, pharmaceutical, healthcare, biotechnology and medical device industries. As the only global specialist provider […]
Factory-CRO Group Announces New Name, Avania
This article was originally published on the Avania website Factory-CRO Group, a medical technology contract research organization (CRO) formed by the merger of BBA (Boston, U.S.), Factory CRO (Netherlands), Five Corners (Australia), and MileStone Research Organization (San Diego, U.S.), is pleased to announce its rebranding as Avania. Avania brings knowledgeable experts together to form a […]
CT:IQ launches Clinical Trial Site Recruitment Guide
CT:IQ has launched a practical tool to help research sites navigate the challenges of recruiting participants for clinical trials. The CT:IQ GREET project (Guidance to Recruitment Examining Experiences at Trial sites) identified barriers and enablers to recruitment at a site level and developed best practice recommendations in the form of the Clinical Trial Site Recruitment Guide. It is widely accepted and recognised that clinical […]
CT:IQ launches checklist to support Australian research sites
CT:IQ, a collaborative of Australian clinical trial stakeholders who aim to develop and implement recommendations that will improve the impact, quality and efficiency of clinical trials, is excited to launch the Early Phase Trials Best Practice Checklist. The checklist was developed as a single source of best practice recommendations, tools and resources to help ensure […]
A message from Leanne Weekes – CT:IQ Programme Director
Our priority is the safety and wellbeing of our talented staff, CT:IQ members, our stakeholders and their families in the current environment. Following the declaration of the COVID-19 (coronavirus) pandemic, CT:IQ have transitioned to a work from home arrangement for the time being. As part of the social distancing measures we are implementing, we now […]
CT:IQ Webinar
Join us for a free webinar on Wednesday 18 September with Praxis Australia and learn about CT:IQ’s clinical trial projects, future plans and the benefits of becoming a CT:IQ member. CT:IQ are conducting five projects in 2019 selected and prioritised against the needs of the sector by our Steering Committee members in the following areas: […]
Evrima Technologies joins Steering Committee
Evrima Technologies transforms clinical trial recruitment by connecting researchers, clinicians and patients together to accelerate research and bring new treatments to patients who need them.
South Australia Clinical Trials Group joins Steering Committee
The “South Australia Clinical Trials Group” is a collection of organisations which includes University of Adelaide, University of South Australia, Flinders University, SA Health Department for Health and Wellbeing, SA Health and Medical Research Institute and the Central Adelaide Local Health Network.
NSW Office for Health and Medical Research joins Steering Committee
NSW Health aims to establish NSW as a global centre of excellence in health and medical research innovation.